Embryo Biopsy (PGT/PGS)
Preimplantation genetic testing to screen embryos before transfer.
About This Treatment
Preimplantation genetic testing (PGT), performed through embryo biopsy, allows our specialists to screen embryos for chromosomal abnormalities and inherited genetic conditions before transfer. This advanced technique is especially valuable for couples with recurrent pregnancy loss, advanced maternal age, or known genetic carrier status, helping select the healthiest embryos for a successful pregnancy.
Treatment Process
- 1
IVF Embryo Culture
Embryos are cultured in the laboratory through fertilization and early development until they reach the blastocyst stage suitable for biopsy.
- 2
Embryo Biopsy
A few cells are carefully removed from each blastocyst on day 5–7 without harming the embryo's developmental potential.
- 3
Genetic Analysis
Biopsied cells undergo preimplantation genetic testing (PGT-A, PGT-M, or PGT-SR) to screen for chromosomal or inherited conditions.
- 4
Embryo Selection
Results guide selection of genetically normal embryos for transfer, improving the chances of a healthy pregnancy.
- 5
Follow-Up Care
Our team reviews your results, plans embryo transfer or cryopreservation, and provides ongoing support throughout your IVF journey.
Benefits & Advantages
- Reduced risk of miscarriage from chromosomal abnormalities
- Screens for aneuploidy and structural rearrangements
- Identifies inherited genetic conditions before transfer
- Improves implantation and live birth rates
- Ideal for recurrent pregnancy loss or known carrier status
- Informed embryo selection for family balancing when appropriate